These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 33439300)

  • 1. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update.
    Abraham Gnanadass S; Divakar Prabhu Y; Valsala Gopalakrishnan A
    Arch Gynecol Obstet; 2021 Mar; 303(3):631-643. PubMed ID: 33439300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Low Grade Inflammation in Pathogenesis of PCOS.
    Rudnicka E; Suchta K; Grymowicz M; Calik-Ksepka A; Smolarczyk K; Duszewska AM; Smolarczyk R; Meczekalski B
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome.
    Pawelczak M; Rosenthal J; Milla S; Liu YH; Shah B
    J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):356-9. PubMed ID: 25256873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytokines in polycystic ovarian syndrome.
    Ebejer K; Calleja-Agius J
    Gynecol Endocrinol; 2013 Jun; 29(6):536-40. PubMed ID: 23368758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
    Souza Dos Santos AC; Soares NP; Costa EC; de Sá JC; Azevedo GD; Lemos TM
    Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and challenges: interleukin-22 comprehensively regulates polycystic ovary syndrome from metabolic and immune aspects.
    Geng Y; Liu Z; Hu R; Ma W; Wu X; Dong H; Song K; Xu X; Huang Y; Li F; Song Y; Zhang M
    J Ovarian Res; 2023 Jul; 16(1):149. PubMed ID: 37525285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
    Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
    Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperandrogenism, Insulin Resistance, and Acanthosis Nigricans (HAIR-AN) Syndrome Reflects Adipose Tissue Dysfunction ("Adiposopathy" or "Sick Fat") in Asian Indian Girls.
    Agrawal K; Mathur R; Purwar N; Mathur SK; Mathur DK
    Dermatology; 2021; 237(5):797-805. PubMed ID: 33445175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
    González F
    Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and ovarian inflammation in women with polycystic ovary syndrome.
    Zhai Y; Pang Y
    J Reprod Immunol; 2022 Jun; 151():103628. PubMed ID: 35472833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome.
    Kume T; Calan M; Yilmaz O; Kocabas GU; Yesil P; Temur M; Bicer M; Calan OG
    J Endocrinol Invest; 2016 Jul; 39(7):747-54. PubMed ID: 26969461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome.
    Demi R İ; Guler A; Alarslan P; Isil AM; Ucman O; Aslanipour B; Calan M
    Endocrine; 2019 Jul; 65(1):175-183. PubMed ID: 31154608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.